Chemoimmunotherapy of melanoma. Is it time for phase III trials?
U
U
Keilholz
D017326:Clinical Trials, Phase III as Topic; D003131:Combined Modality Therapy; D003606:Dacarbazine / Q000627:therapeutic use*; D006801:Humans; D007167:Immunotherapy; D007376:Interleukin-2 / Q000627:therapeutic use*; D008545:Melanoma / Q000628:therapy*
D007376:Interleukin-2; D003606:Dacarbazine